Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 EUR | -1.82% | -44.62% | -56.80% |
Jun. 04 | Valbiotis Terminates Licensing, Supply Deal With Nestlé Unit | MT |
Jun. 04 | Valbiotis: share price plummets, Nestlé agreement terminated | CF |
Sales 2024 * | 4.8M 5.22M | Sales 2025 * | 21.85M 23.75M | Capitalization | 34.71M 37.73M |
---|---|---|---|---|---|
Net income 2024 * | -12M -13.04M | Net income 2025 * | 1M 1.09M | EV / Sales 2024 * | 3.42 x |
Net cash position 2024 * | 18.3M 19.89M | Net cash position 2025 * | 31.25M 33.96M | EV / Sales 2025 * | 0.16 x |
P/E ratio 2024 * |
-2.12
x | P/E ratio 2025 * |
-2.75
x | Employees | 52 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.94% |
1 day | -1.82% | ||
1 week | -44.62% | ||
Current month | -44.47% | ||
1 month | -51.73% | ||
3 months | -45.73% | ||
6 months | -58.94% | ||
Current year | -56.80% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Pascal Sirvent
CTO | Chief Tech/Sci/R&D Officer | - | 17-08-31 |
Sébastien Bessy
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnès Tixier
BRD | Director/Board Member | - | 19-03-17 |
Laurent Lévy
CHM | Chairman | 53 | 17-02-28 |
Chief Executive Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 2.16 | -1.82% | 319 929 |
24-06-04 | 2.2 | -43.23% | 1,192,296 |
24-06-03 | 3.875 | -0.39% | 15,324 |
24-05-31 | 3.89 | -1.27% | 20,218 |
24-05-30 | 3.94 | +1.03% | 28,118 |
Real-time Euronext Paris, June 05, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.80% | 37.77M | |
+18.64% | 123B | |
+15.25% | 107B | |
-4.09% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.90% | 16.23B | |
+2.55% | 13.43B | |
+24.48% | 11.32B |
- Stock Market
- Equities
- ALVAL Stock